MDClone Overview
MDClone offers an innovative self-service data analytics environment designed to power exploration, discovery, and collaboration throughout healthcare ecosystems, both cross-institutionally and globally. The MDClone ADAMS Platform introduces a fundamentally different approach to healthcare data analysis, exploration, and action by embracing a fast, fluid, and nonlinear process for dynamic data exploration. The platform is designed for synthetic data, continuous data feeds, longitudinal data, unstructured data, flexible infrastructure, and third-party tool integration. The powerful underlying infrastructure of the MDClone ADAMS Platform allows users to overcome common barriers in healthcare in order to organize, access, and protect the privacy of patient data while accelerating research, improving operations and quality, and driving innovation to deliver better patient outcomes. MDClone serves major health systems, payers, and life sciences customers in the United States, Canada, and Israel, including the VHA ecosystem (Department of Veterans Affairs), The National Institutes of Health, Intermountain Healthcare, Regenstrief Institute, The Ottawa Hospital, and Sheba Medical Center, among other notable institutions.
Cumulative Funding Raised Over Time ($)
$26.0MAug 2019
$36.3MFeb 2018
$41.3MJan 2016
$104.3MMar 2022
Latest News
growth-positive
Sheba Medical Center Inaugurates World's First ADAMS Center with MDClone Platform | MDClone
MDClone, a data analytics and synthetic data company, has launched the first ADAMS Center at Sheba Medical Center in Israel. The ADAMS Center is a model designed to improve quality and performance by leveraging data. It acts as a hub for data-driven activities, aiming to enhance care delivery, access to care, and cost management for over 1.6 million annual patient visits. The center has increased the volume and value of projects by empowering clinical teams to interact with data. The data is made available to clinical teams through the MDClone Platform, which organizes a wide range of clinical and operational information into one system.
CustomersPartners
growth-positive
MDClone Wins Second Consecutive “Best Healthcare Big Data Platform” Award in Annual MedTech Breakthrough Awards Program
MDClone, a data analytics and synthetic data company, has been recognized as the Best Healthcare Big Data Platform for the second consecutive year in the annual MedTech Breakthrough Awards program. The MDClone ADAMS Platform, which includes a healthcare-oriented data lake and discovery tool, enables streamlined organization, access, and action of data from any patient-oriented source. The company has implemented its platform across the entire Israeli market, including major hospitals and HMOs, and has expanded across the U.S. and Canada.
CustomersExpand
growth-positive
Israeli digital health co MDClone raises $63m
Israeli digital health company MDClone has completed a $63 million Series C financing round. The funding was led by new investors Warburg Pincus and Viola Growth, with participation from existing investors aMoon, LightSpeed Venture Partners, and OrbiMed. MDClone provides clinicians and healthcare professionals with a data analytics platform that enables self-service data exploration and action. The company plans to use the funds to expand its healthcare data solutions into new regional and vertical markets, as well as develop new capabilities. MDClone also intends to make key recruitments to enhance data access and self-service data exploration. The funding round marks a positive growth impact for the company.
InvestmentExpand
MDClone, The Ottawa Hospital Continue Partnership to Drive Healthcare Innovation through Self-Service Data Exploration
growth-positive
Israel's MDClone Uses Synthetic Data To Help Health Providers Roll Out Better, Smarter Care
Israeli healthcare data startup MDClone has developed a platform, ADAMS, to organize and democratize healthcare data in real-time. The platform utilizes synthetic data technology to generate artificial datasets that mirror real-world data while maintaining patient privacy. MDClone has attracted prominent investors and raised over $40 million to date. The company has also formed partnerships with healthcare providers internationally, including the Ottawa Hospital, the Jewish General Hospital, and the National Institute of Health. MDClone recently collaborated with the VHA Innovation Ecosystem to improve access to clinical data for the United States Department of Veterans Affairs. The company was recognized as a 2021 Technology Pioneer by the World Economic Forum. MDClone aims to continue advancing digital healthcare through global cooperation and joint projects.
PartnersInvestment
| Sector | Health Tech & Life Sciences |
Funding
| Total funding | $104.25M |
| Last funding | $63M |
| Stage | C |
| Rounds | 4 |
| Investors | 5 |
Team Members
8
Employees: 51-200
Web & Social Links
| Website | mdclone.com |
| Careers | Careers page |
Locations
HaEnergia Street 77, Be'er Sheva, Israel
Canada
Chicago, IL, USA
Photos & Videos
6 item(s)
MDClone Business
Business models
B2B
Product stage
Released
Employees
51-200
Sector
Health Tech & Life SciencesDigital HealthcareClinical WorkflowTarget Customer
Healthcare & Life SciencesLife SciencesHealthcareProvidersCore Technology
Platforms & InterfacesSoftwareWebArtificial IntelligenceNatural Language ProcessingGenerative AITags (19)
search-engineclinical-dataemrweb-platformdigital-healthcaredata-analyticssoftware-applicationsmedical-databig-dataartificial-intelligenceprivacy-protectionhealthcare-providerssynthetic-dataclinical-workflownatural-language-processingcollaborationhospitalsdata-protectionclinical-trialsGeographic Markets
North AmericaIsraelEuropeAsiaMDClone Financials
$104.25M
Total funding
Undisclosed
Capital raised
$63M
Last funding
C
Funding stage
4
Total rounds
5
Investors
Cumulative Funding Raised Over Time ($)
$26.0MAug 2019
$36.3MFeb 2018
$41.3MJan 2016
$104.3MMar 2022
Private Equity Funding
C Round
Mar 2022
$63M
Viola Growth (Lead)
,
aMoon Fund, Lightspeed Venture Partners, Warburg Pincus, OrbiMed
B Round
Aug 2019
$26M
aMoon Fund (Lead)
,
OrbiMed, Lightspeed Venture Partners
A Round
Feb 2018
$10.25M
Lightspeed Venture Partners, OrbiMed
Seed
Jan 2016
$5M
OrbiMed
MDClone Lifecycle
Cumulative Funding Raised Over Time
$26.0MAug 2019
$36.3MFeb 2018
$41.3MJan 2016
$104.3MMar 2022
All Events
C Round
Mar 2022
$63M
Viola Growth (Lead)
,
aMoon Fund, Lightspeed Venture Partners, Warburg Pincus, OrbiMed
B Round
Aug 2019
$26M
aMoon Fund (Lead)
,
OrbiMed, Lightspeed Venture Partners
A Round
Feb 2018
$10.25M
Lightspeed Venture Partners, OrbiMed
Seed
Jan 2016
$5M
OrbiMed
MDClone News
25 articles
growth-positive
Sheba Medical Center Inaugurates World's First ADAMS Center with MDClone Platform | MDClone
MDClone, a data analytics and synthetic data company, has launched the first ADAMS Center at Sheba Medical Center in Israel. The ADAMS Center is a model designed to improve quality and performance by leveraging data. It acts as a hub for data-driven activities, aiming to enhance care delivery, access to care, and cost management for over 1.6 million annual patient visits. The center has increased the volume and value of projects by empowering clinical teams to interact with data. The data is made available to clinical teams through the MDClone Platform, which organizes a wide range of clinical and operational information into one system.
CustomersPartners
growth-positive
MDClone Wins Second Consecutive “Best Healthcare Big Data Platform” Award in Annual MedTech Breakthrough Awards Program
MDClone, a data analytics and synthetic data company, has been recognized as the Best Healthcare Big Data Platform for the second consecutive year in the annual MedTech Breakthrough Awards program. The MDClone ADAMS Platform, which includes a healthcare-oriented data lake and discovery tool, enables streamlined organization, access, and action of data from any patient-oriented source. The company has implemented its platform across the entire Israeli market, including major hospitals and HMOs, and has expanded across the U.S. and Canada.
CustomersExpand
growth-positive
Israeli digital health co MDClone raises $63m
Israeli digital health company MDClone has completed a $63 million Series C financing round. The funding was led by new investors Warburg Pincus and Viola Growth, with participation from existing investors aMoon, LightSpeed Venture Partners, and OrbiMed. MDClone provides clinicians and healthcare professionals with a data analytics platform that enables self-service data exploration and action. The company plans to use the funds to expand its healthcare data solutions into new regional and vertical markets, as well as develop new capabilities. MDClone also intends to make key recruitments to enhance data access and self-service data exploration. The funding round marks a positive growth impact for the company.
InvestmentExpand
MDClone, The Ottawa Hospital Continue Partnership to Drive Healthcare Innovation through Self-Service Data Exploration
growth-positive
Israel's MDClone Uses Synthetic Data To Help Health Providers Roll Out Better, Smarter Care
Israeli healthcare data startup MDClone has developed a platform, ADAMS, to organize and democratize healthcare data in real-time. The platform utilizes synthetic data technology to generate artificial datasets that mirror real-world data while maintaining patient privacy. MDClone has attracted prominent investors and raised over $40 million to date. The company has also formed partnerships with healthcare providers internationally, including the Ottawa Hospital, the Jewish General Hospital, and the National Institute of Health. MDClone recently collaborated with the VHA Innovation Ecosystem to improve access to clinical data for the United States Department of Veterans Affairs. The company was recognized as a 2021 Technology Pioneer by the World Economic Forum. MDClone aims to continue advancing digital healthcare through global cooperation and joint projects.
PartnersInvestment
MDClone Awarded as Technology Pioneer by World Economic Forum
Growth-Positive
Intermountain and MDClone pairing saves money as both populations and individual patients are better understood
Intermountains partnership with MDClone, a technology platform that offers self-service data analytics, has resulted in significant improvements for patients with chronic kidney disease and end stage renal disease. The collaboration has revamped Intermountains kidney care, decreasing admissions by about 90% and producing savings of $30 million in a year and a half. The platform allows the health system to organize patient data in a linear timeline and add virtually any information with a timestamp. This has enabled early identification of patients and their conditions. Intermountain is also able to publish synthetic data on patients without compromising personal health information.
PartnersCustomers
growth-positive
MDClone Named "Best Healthcare Big Data Platform" in 2021 MedTech Breakthrough Awards Program
MDClone, a healthcare data analytics company, has been awarded the “Best Healthcare Big Data Platform” Award at the fifth annual MedTech Breakthrough Awards. The companys MDClone ADAMS Platform enables healthcare organizations to securely access, organize and share patient data instantly. The platform leverages massive data assets into operational, research and innovation-oriented insights and actions that impact patient health. The MedTech Breakthrough Awards program recognizes the top companies, technologies and products in the global health and medical technology market.
Customers
growth-positive
MDClone Partners with VHA Innovation Ecosystem to Provide Better, Smarter, Faster Healthcare to U.S. Veterans
Digital health company MDClone has partnered with the VHA Innovation Ecosystem, a division of the United States Department of Veterans Affairs (VA), to democratize data at the Veterans Health Administration (VHA). The partnership will provide secure access to clinical data to improve the health of over nine million veterans. The MDClone platform will allow non-technical users to quickly ask important questions, find answers, and take action, shortening timelines for quality improvement, innovation, and clinical research. The initial collaboration will focus on suicide prevention, chronic disease management, precision medicine, health equity, and COVID-19.
PartnersExpand
growth-positive
The Global Network powers healthcare collaboration
Israeli health-tech company MDClone has launched The Global Network, a research and innovation sharing platform for healthcare organizations. The platform, powered by MDClones data analysis technology, allows medical organizations and research centers to share knowledge and collaborate to improve patient care. The Global Network includes healthcare organizations from Israel, Canada, and the U.S. MDClones platform provides patient confidentiality by creating synthetic data for 30 million patients, enabling healthcare organizations to pull and share effective solutions for collaborative treatments. The Global Network will focus on health services, clinical medicine, and precision medicine in its first year. MDClone was founded in 2016 and is headquartered in Beer Sheva, Israel.
Partners
N/A
Blog
The article does not provide any specific information about Monocl or any events related to the company.
Unknown
NIH Partners with Israeli Startup to Generate Synthetic COVID-19 Data
The article content is not provided.
growth-positive
https://www.jpost.com/israel-news/israeli-company-fights-coronavirus-with-big-data-625507
Beersheba-based company MDClone has developed a pandemic package to help health systems fight the COVID-19 virus. The company provides big-data solutions for healthcare systems and has developed a specific pandemic package by adding content specific to the virus. The package allows for effective collection and analysis of data to make better decisions in fighting the disease. The platform takes data directly from electronic medical records in hospitals. The Pandemic Response Package is already operating at Sheba Medical Center and will be installed in other systems in Israel, the US, and Canada soon.
CustomersPartners
MDClone Announces COVID-19-Specific Application, Enabling Healthcare Industry Collaboration and Innovation to Combat Coronavirus with Global Data Network
MDClone Expands to Canada
growth-positive
MDClone's data platform enters Canada, Cityblock augments Tufts Health Plan program and more digital health news briefs
MDClone, a patient data-focused startup, has partnered with The Ottawa Hospital to debut its platform in Canada. The partnership will provide the hospitals practitioners and researchers with a synthetic set of patient data that ensures patient privacy. This expansion marks MDClones entry into its third country, following the US and Israel.
Partners
growth-positive
Medical Data Startup MDClone Raises $26 Million
Israel-based medical data management startup MDClone Ltd. has closed a $26 million series B funding round. The funding was led by aMoon, with participation from existing investors OrbiMed Israel Partners and Lightspeed Venture Partners. MDClone develops a system that ensures patient confidentiality during the analysis of medical data. The companys system generates datasets combining real and fictitious patients, allowing researchers to conduct tests without compromising personal details. MDClone has clients such as Washington University School of Medicine, Intermountain Healthcare, Maccabi Healthcare Services, and Clalit Healthcare Services. The CEO and co-founder of MDClone, Ziv Ofek, previously founded dbMotion Ltd., which was acquired by Allscripts Healthcare Solutions Inc. for $235 million.
Investment
https://www.yazamut360.bgu.ac.il/feed/mdclone
growth-positive
MDClone Launches New Phase of Collaboration With Washington University in St. Louis
MDClone has announced a new phase of collaboration with the Institute for Informatics at Washington University School of Medicine. The collaboration aims to broaden the implementation of MDClones big data platform, called the MDClone Healthcare Data Sandbox, which allows researchers to analyze healthcare data while preserving patient privacy. The platform creates a synthetic copy of healthcare data to protect patient privacy while providing valuable data for analysis and research. The Institute for Informatics will work with MDClone to explore opportunities for improving healthcare by providing access to large sets of data for researchers to explore. The collaboration has a growth-positive impact on MDClone.
Partners
growth-positive
MDClone to Showcase World's First Healthcare Data Sandbox Powered by Groundbreaking Synthetic Data Engine at HIMSS19
MDClones Healthcare Data Sandbox and Synthetic Data Engine will be showcased at HIMSS19 Global Conference & Exhibition. The Healthcare Data Sandbox is a big data platform powered by synthetic data that allows users to ask and answer any question. Unlike existing methods of de-identification, MDClones synthetic data has zero-risk of exposing patient identity. Visitors to MDClones booth will be able to interact with the Healthcare Data Sandbox and learn how it is being utilized at Rambam Health Care Campus and with its partners. MDClone has installed with over 80% of the Israeli healthcare market and has recently entered the U.S. market with installations at Washington University, Intermountain Healthcare, and Regenstrief Institute.
PartnersCustomers
growth-positive
Intermountain Healthcare and startup MDClone launch data-focused collaboration
Intermountain Healthcare has partnered with Israeli startup MDClone to analyze patient data and improve patient care. The collaboration involves loading Intermountains data into MDClones Sandbox to understand critical decision points in a patients care journey. The goal is to enable Intermountain caregivers to better understand and manage patients. The initial focus will be on kidney disease and end-stage renal disease, with plans to expand to other clinical areas like heart failure and stroke care. MDClone, founded in 2016 and led by the team of dbMotion, will turn Intermountains data into insights for higher-quality and lower-cost patient care.
Partners
growth-positive
Regenstrief Institute-MDClone Partnership to Accelerate Data-Driven Medical Research - Regenstrief Institute
Regenstrief Institute and MDClone have formed a partnership to speed up access to data for medical research while ensuring patient privacy. The partnership aims to deliver research-ready, privacy-preserving synthetic data, enabling new discoveries, improving quality, and reducing costs. MDClones big data platform will be applied to the data managed by Regenstrief for its health system partners, allowing for more rapid and secure data sharing with research partners. The partnership will work with the Indiana University School of Medicine, Indiana University Health, Eskenazi Health, and the Indiana Health Information Exchange. The new data platform is being installed at Regenstrief to better connect data with researchers.
Partners
growth-positive
Medical data co MDClone raises $10m
MDClone, a medical technology company, has raised $10 million in funding from OrbiMed Advisors LLC and Lightspeed Ventures. The company has developed a unique system for preserving the privacy of information while allowing researchers to use it. MDClone generates synthetic data that can be used for research without obtaining ethical approval. The company has already conducted important trials using its software, and researchers have found sufficient results to write articles. MDClone has also signed an overseas agreement with the Institute of Informatics at the Washington University School of Medicine. The funding will enable MDClone to continue expanding in the US and reach additional markets.
InvestmentPartners
growth-positive
Institute for Informatics at Washington University School of Medicine in St. Louis Joins Forces with Israeli Startup MDClone to Enable Data-Driven Healthcare Discovery and Innovation
MDClone has signed a strategic partnership agreement with the Institute for Informatics (I2) at Washington University School of Medicine in St. Louis. The partnership aims to introduce a new approach to healthcare data access, privacy, analytics, and research. MDClones solution enhances the utility of data and eliminates the risk of releasing identifiable patient information. This partnership represents MDClones first expansion outside of Israel. The agreement was made possible through the support of GlobalSTL and St. Louis healthcare ecosystem. The partnership will allow clinicians and researchers at Washington University to extract data and insights in real-time using MDClones Healthcare Data Platform. The synthetic data provided by MDClone can be analyzed as if it were original data but is 100 percent unidentified. The partnership aims to democratize data and improve patient care through a rapid learning healthcare system.
Partners
growth-positive
Big data co MDClone protects patient confidentiality
Israeli company MDClone has developed a technology that allows researchers and doctors to conduct medical research using big data databases of patients without compromising their privacy. The system creates fictitious patients with false characteristics, allowing researchers to analyze the data while preserving the anonymity of real patients. The technology has been successfully piloted at Haifas Rambam Health Care Campus in Israel. The CEO, CTO, and CFO of MDClone have a background in digital medicine and healthcare innovation. The technology is expected to facilitate breakthroughs in medical knowledge, increase research capabilities, and cut costs.
Customers
MDClone Team
Lidor Hamama
Employee Info
| Employees (range) | 51-200 |
| Exact count | 131 |
| Team members | 8 |
Similar Companies
Similar companies data is computed dynamically and not stored in the entity profile. This section requires implementing a similarity query (e.g. by classification overlap, sector, district).
This entity has 13 classification IDs that could be used for matching.
MDClone Internal
Recent Updates
No update log entries.
Note: Free-text notes visible in the original Finder "Internal" tab are not present in the imported profile data. Only the update audit log is available.
Admin Info
| Confidence | 98/100 |
| Missing | markets |
| BI Verification | Yanina Wainscheinker |
| Registrar ID | 515268100 |
| Crunchbase | mdclone |
| Last updater | Matan Eblagon |
| Updater email | matane@sncentral.org |
| Last update | 2024-02-26T00:00:00.000Z |
| Created | 2015-12-22T00:00:00.000Z |
| Claimed | Yes |